Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15167 | 659 | 22.9 | 37% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1013 | 9860 | CHLORAMPHENICOL//JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS//TETRACYCLINES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LONG ACTING OXYTETRACYCLINE | Author keyword | 6 | 80% | 1% | 4 |
2 | LOCAL TOLERANCE | Author keyword | 4 | 33% | 2% | 10 |
3 | CAS 24390 14 5 | Author keyword | 3 | 100% | 0% | 3 |
4 | POST INJECTION PRECIPITATION | Author keyword | 2 | 67% | 0% | 2 |
5 | PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU | Address | 2 | 31% | 1% | 5 |
6 | INJECTION SITE LESION | Author keyword | 1 | 100% | 0% | 2 |
7 | INJECTION SITE LESIONS | Author keyword | 1 | 100% | 0% | 2 |
8 | PHARMACOL TOXICOL GEN THER Y | Address | 1 | 100% | 0% | 2 |
9 | SWINE VET SERV | Address | 1 | 100% | 0% | 2 |
10 | VET PHYSIOL ENDOCRINOL | Address | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LONG ACTING OXYTETRACYCLINE | 6 | 80% | 1% | 4 | Search LONG+ACTING+OXYTETRACYCLINE | Search LONG+ACTING+OXYTETRACYCLINE |
2 | LOCAL TOLERANCE | 4 | 33% | 2% | 10 | Search LOCAL+TOLERANCE | Search LOCAL+TOLERANCE |
3 | CAS 24390 14 5 | 3 | 100% | 0% | 3 | Search CAS+24390+14+5 | Search CAS+24390+14+5 |
4 | POST INJECTION PRECIPITATION | 2 | 67% | 0% | 2 | Search POST+INJECTION+PRECIPITATION | Search POST+INJECTION+PRECIPITATION |
5 | INJECTION SITE LESION | 1 | 100% | 0% | 2 | Search INJECTION+SITE+LESION | Search INJECTION+SITE+LESION |
6 | INJECTION SITE LESIONS | 1 | 100% | 0% | 2 | Search INJECTION+SITE+LESIONS | Search INJECTION+SITE+LESIONS |
7 | ANIMAL MEDICATION | 1 | 50% | 0% | 1 | Search ANIMAL+MEDICATION | Search ANIMAL+MEDICATION |
8 | CONCENTRATIONS IN TISSUES | 1 | 50% | 0% | 1 | Search CONCENTRATIONS+IN+TISSUES | Search CONCENTRATIONS+IN+TISSUES |
9 | CONVENTIONAL FORMULATION | 1 | 50% | 0% | 1 | Search CONVENTIONAL+FORMULATION | Search CONVENTIONAL+FORMULATION |
10 | DRUG DEPLETION | 1 | 50% | 0% | 1 | Search DRUG+DEPLETION | Search DRUG+DEPLETION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METABOLIC INERTNESS | 27 | 92% | 2% | 11 |
2 | RESIDUE ASPECTS | 27 | 92% | 2% | 11 |
3 | TOP SIRLOIN BUTTS | 15 | 82% | 1% | 9 |
4 | OXYTETRACYCLINE FORMULATIONS | 11 | 100% | 1% | 6 |
5 | LONG ACTING PREPARATION | 9 | 83% | 1% | 5 |
6 | INJECTION SITE LESIONS | 7 | 64% | 1% | 7 |
7 | SERUM PHARMACOKINETICS | 6 | 71% | 1% | 5 |
8 | ACTING PARENTERAL FORMULATION | 6 | 100% | 1% | 4 |
9 | LOCAL TOLERANCE | 4 | 56% | 1% | 5 |
10 | ENZYME ACTIVITY CONCENTRATION | 2 | 50% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines | 2006 | 153 | 31 | 45% |
CLINICAL PHARMACOKINETICS OF DOXYCYCLINE AND MINOCYCLINE | 1988 | 160 | 31 | 68% |
Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release | 1996 | 23 | 27 | 70% |
Injection-site lesions in beef subprimals: Incidence, palatability consequences, and economic impact | 1997 | 14 | 5 | 100% |
Residues of veterinary drugs at injection sites | 2007 | 7 | 40 | 55% |
TETRACYCLINES, MOLECULAR AND CLINICAL ASPECTS | 1992 | 194 | 130 | 16% |
Drug administration to poultry | 2002 | 23 | 9 | 22% |
DOXYCYCLINE | 1982 | 68 | 2 | 100% |
Critical review on the withdrawal period calculation for injection site residues | 2006 | 4 | 5 | 60% |
Issues and challenges in developing long-acting veterinary antibiotic formulations | 2004 | 16 | 41 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACEUT SCI BIOPHARMACEUT MIZUHO KU | 2 | 31% | 0.8% | 5 |
2 | PHARMACOL TOXICOL GEN THER Y | 1 | 100% | 0.3% | 2 |
3 | SWINE VET SERV | 1 | 100% | 0.3% | 2 |
4 | VET PHYSIOL ENDOCRINOL | 1 | 40% | 0.3% | 2 |
5 | ENVIRONM TOXICOL EXTENS | 1 | 33% | 0.3% | 2 |
6 | ADV TECHNOL CORP ATCSA | 1 | 50% | 0.2% | 1 |
7 | BIOCHEM NUTR TOXICOL | 1 | 50% | 0.2% | 1 |
8 | CYTOL HISTOL EMBRIOL | 1 | 50% | 0.2% | 1 |
9 | LEVENT 4 | 1 | 50% | 0.2% | 1 |
10 | PARKER E MAHAN IAL PAIN | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000266030 | VET BASIC MED SCI//CYCLOSPORINE METABOLISM//DOSE REGIME |
2 | 0.0000234412 | DRUG DELIVERY DISPOSIT DYNAM GRP//2 3 5 6 TETRAMETHYL P PHENYLENEDIAMINE//ANESTHETICS DISSOCIATIVE |
3 | 0.0000151601 | TETRACYCLINES//OXYTETRACYCLINE//TETRACYCLINE ANTIBIOTICS |
4 | 0.0000144516 | ADITOPRIM//SULPHAMONOMETHOXINE//VET MED HERD HLTH AMBULATORY CLIN |
5 | 0.0000139429 | 5 BROMODEOXYURIDINE//AT TRACT//EXCESS THYMIDINE |
6 | 0.0000127990 | CEFQUINOME//PORPHYROMONAS LEVII//BOVINE NECROTIC VULVOVAGINITIS |
7 | 0.0000115893 | MARBOFLOXACIN//ENROFLOXACIN//DANOFLOXACIN |
8 | 0.0000097972 | CATEDRA BIOFIS//PREMI R TEST//ANTIBIOTIC RESIDUES |
9 | 0.0000083973 | PHARMAKOL PHARM TOXIKOL//EXTRA LABEL USE//SUPPLY TO ANIMAL OWNERS |
10 | 0.0000076655 | RUMINANT DIS EPIDEMIOL//SUCTION BLISTER METHOD//SKIN BLISTER FLUID CONCENTRATION |